Philip S Barie

Dr. Philip S Barie

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
Massimo SartelliMassimo Sartelli
Massimo Sartelli
MBMarja A. Boermeester
Marja A. Boermeester
MCMiguel Cainzos
Miguel Cainzos
ACand Federico Coccolini
and Federico Coccolini
SJStijn W. de Jonge
Stijn W. de Jonge
PBPhilip S Barie
Philip S Barie
Surgical site infections (SSIs) are the most common adverse event occurring in surgical patients. Optimal prevention of SSIs requires the bundled integration of a variety of measures before, during, and after surgery. Surgical antibiotic prophylaxis (SAP) is an effective measure for preventing SSIs. It aims to counteract the inevitable introduction of bacteria that colonize skin or mucosa into the surgical site during the intervention. This document aims to guide surgeons in appropriate administration of SAP by addressing six key questions. The expert panel identifies a list of principles in response to these questions that every surgeon around the world should always respect in administering SAP.

7 November 2014 in International Journal of Surgery
Verified
Journal Article
Closed access
PDF file
TSTushar Samdani
Tushar Samdani
FPFredric M. Pieracci
Fredric M. Pieracci
SESoumitra R. Eachempati
Soumitra R. Eachempati
JBJaime Benarroch-Gampel
Jaime Benarroch-Gampel
AWAlex Weiss
Alex Weiss
GNGarrett Nash
Garrett Nash
Introduction: Management of the immunosuppressed patient with diverticular disease remains controversial. We report the largest series of colon cancer patients undergoing chemotherapy and hospitalized for acute diverticulitis, to determine whether recent treatment with systemic chemotherapy is associated with increased risk for/increased severity of recurrent diverticulitis. Methods: Retrospective cohort study of adult patients hospitalized for an initial episode of acute colonic diverticulitis at Memorial Sloan Kettering Cancer Center, 1988–2004. Outcomes in patients receiving systemic chemotherapy within one month of admission for diverticulitis (“Chemo”) were compared to outcomes of patients not receiving chemotherapy within the past month (“No-chemo”). Results: A total 131 patients met inclusion criteria. Chemo patients did not differ significantly from No-chemo group in terms of severity of acute diverticulitis at index admission (13.2% vs. 4.4%, respectively, p = 0.12), resumption of chemotherapy (median 2 months), failure of non-operative management (13.2% vs 4.4%, respectively, p = 0.12), frequency of recurrence (20.5% vs 18.5%), hospital length of stay (p = 0.08), and likelihood of interval resection (24.0% vs. 16.2%, respectively, p = 0.39). Chemo patients recurred with more severe disease, were more likely to undergo emergent surgery (75.0% vs. 23.5%, respectively, p = 0.03), and were more likely to be diverted (100.0% vs. 25.0%, respectively, p = 0.03). Chemo patients were significantly more likely to incur a postoperative complication (100% vs 9.1% p < 0.01) following interval resection. Overall mortality was significantly higher in the Chemo vs. No-chemo group. Median survival in Chemo patients was 3.4 years; in No-chemo patients, median survival was not reached at 10 years.Conclusion: Our data do not support routine elective surgery for acute diverticulitis in patients receiving chemotherapy. Non-operative management in the acute or interval setting appears preferable whenever possible.

1 May 2004 in Surgical Infections
Verified
Journal Article
Closed access
PBPhilip S Barie
Philip S Barie

7 February 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
PAPaolo de Angelis
Paolo de Angelis
EKElinore J. Kaufman
Elinore J. Kaufman
PBPhilip S Barie
Philip S Barie
NLNicole E. Leahy
Nicole E. Leahy
RWRobert J. Winchell
Robert J. Winchell
MNMayur Narayan
Mayur Narayan

1 January 1996 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
MTMia Talmor
Mia Talmor
PBPhilip S Barie
Philip S Barie
DSDaniel Shapiro
Daniel Shapiro
LHLloyd A. Hoffman
Lloyd A. Hoffman
GLGregory LaTrenta
Gregory LaTrenta
Taxicab accidents are a common occurrence in New York City. This review was undertaken to characterize the nature of craniofacial injuries that result from taxicab accidents. Data were collected on 16 patients who required admission to trauma or plastic and reconstructive surgery services, after sustaining craniofacial injury as a result of a taxicab accident. Front-end deceleration collisions were the most common mechanism of injury. Fifty-six percent of the patients were thrown against the bulletproof, Plexiglas driver safety divider and sustained an injury most commonly to the anterior midface. Both bony and softtissue injuries were common in the entire group. Complex facial fractures were sustained by 56% of patients, with nasal-septal fractures most common, followed by naso-ethmoid-orbital, anterior frontal, anterior maxillary, and Le Fort I and II fractures. Only 1 patient in the group was wearing a seat belt and that patient was a driver. Given the high incidence of craniofacial injury, appropriate safety standards for taxicabs must be initiated, including the reevaluation of the utility of the safety divider and mandatory seat belt use for rear-seat passengers. Talmor M, Barie PS, Shapiro D, Hoffman LA, LaTrenta G. Craniofacial injuries resulting from taxicab accidents in New York City. Ann Plast Surg 1996:36:1-6

1 December 2021 in Surgical Infections
Verified
Journal Article
Closed access
SSShawn L. Shah
Shawn L. Shah
PBPhilip S Barie
Philip S Barie
MBMatthew E. Bronstein
Matthew E. Bronstein
PCPhilip H. Chang
Philip H. Chang
CGCameron J. Gibson
Cameron J. Gibson
MNMayur Narayan
Mayur Narayan